Pressemitteilung

Sanity Group has expanded its management team

SanityGroup_Management_Vlnr_FlorianBlaschke-LauraSimonow-FinnHaensel-MaxNarr-Dr.KonstantinRutz_LowRes_204_Fotocredit_SanityGroup-MaximilianKoenig_Headerimage
Berlin-based health and life science company Sanity Group has expanded its management team around CEO Finn Hänsel: Dr. Konstantin Rutz is the new Managing Director of the Group's Medical division, Laura Simonow is Managing Director of the Consumer divison Sanity Care. The management team has also been broadened at Group level.

Dr. Konstantin Rutz has joined the Sanity Group after more than five years at Boston Consulting Group (BCG), where he was a project manager in the Health Care division. He has taken over as Managing Director of Sanity Group’s Medical division. The 36 year old lawyer has several years of experience in the pharmaceutical, life science and medtech sectors and has most recently been particularly involved in pharmaceutical commercial issues.

Alongside Dr. Konstantin Rutz, Tobias Wirth has also joined Sanity Group: He has more than 15 years of sales experience in the pharmaceutical sector, particularly in the indication areas of pain and oncology as well as in the area of medical cannabis, and is now responsible for sales and marketing at Sanity Group’s Medical division. He spent eight years at Teva GmbH in various management roles and was most recently at Cannamedical Pharma GmbH, before joining Sanity Group.

Since May 2022, Laura Simonow, Founder of the functional natural cosmetics brand This Place, has been Managing Director of the Consumer Health division Sanity Care with the brands This Place and VAAY.

Florian Blaschke joined Sanity Group in January 2022 as Chief Finance Officer, responsible for the Group’s finances. Max Narr, who has been with the Sanity Group since 2020 and is Managing Director of the joint venture Endosane Pharmaceuticals, is responsible for Strategy and M&A at Sanity Group as Chief Investment Officer.

The new management structure is also due to the decision of Sanity Group co-founder Fabian Friede to step down from the operational side of the business for personal reasons. Friede will remain with the company as a shareholder and advisor.

About Sanity Group
Berlin-based health and life science company Sanity Group aims to improve people’s quality of life through the beneficial use of cannabinoids and the utilization of the endocannabinoid system. The focus is on cannabinoid-based pharmaceuticals and consumer goods. In parallel, Sanity Group is also working and researching new medical products, innovative dosage forms, and technological products and services. Sanity Group, founded in Berlin in 2018 by Finn Age Hänsel and Fabian Friede, includes Vayamed and AVAAY Medical (medical cannabis), Endosane Pharmaceuticals (finished pharmaceuticals), Belfry Medical (medical products and digital applications), VAAY (wellbeing) and This Place (functional natural cosmetics). Near Frankfurt am Main, Sanity Group operates a production facility for cannabis extracts. More information at sanitygroup.com/press.

Image: Sanity Group – Maximilian König (c)